Key takeaways
- Beiersdorf launches Eucerin Dermopure Clinical Probiom8 with live probiotics for acne-prone skin.
- The formula aims to rebalance the skin microbiome rather than broadly eliminating bacteria.
- The launch taps rising microbiome innovation and a growing global acne skin care market.

Beiersdorf has introduced a skin care solution for acne-prone skin under its Eucerin brand, called Dermopure Clinical Probiom8. The product uses a patented active ingredient that contains live probiotics native to healthy skin.
According to Beiersdorf, the probiotics in the formula help restore a balanced skin microbiome instead of eliminating bacteria broadly. Its launch is built on over 20 years of microbiome research and over 120 studies.
The FMCG company says Dermopure Clinical Probiom8 comes in response to a growing market for acne care. It cites data that around one in five people globally have acne-prone skin. Among those aged 16 to 24, the number rises to nearly one in three.
Beiersdorf reports that the global market for acne skin care reached €4.6 billion (US$5.35 billion) in 2025, after growing nearly 9% over the previous five years.
Beyond tapping into microbiome-friendly formulation trends, the product also contains the active ingredient Topic.A, which contains two strains of bacteria naturally found on healthy skin.
These bacterial strains are kept in a dormant state and become active once the product is applied. Beiersdorf describes this approach as different from traditional acne care formulations that typically target all bacteria, including those that are beneficial.
“Dermopure Clinical Probiom8 … demonstrates how we translate long-term investments in research and development into cosmetic solutions that are relevant to our consumers,” says Burcu Andreae-Nehlsen, brand president of Derma & Healthcare at Beiersdorf.
“For Eucerin, this innovation opens new opportunities in a market that affects millions of people worldwide and ranks among the largest skin care categories.”
Eucerin’s acne care solution uses probiotics designed to support a balanced skin microbiome.
Probiotics pick up in microbiome innovation
Across the cosmetics industry, companies are doubling down on microbiome innovation, as its role in skin health is increasingly explored and valued by consumers. Innova Market Insights data shows that global personal care launches with microbiome-friendly claims are on the rise, recording a 33% compound annual growth rate.
In July, a study from Poland made a major breakthrough in microbiome science by cracking probiotic skin care’s preservation problem. Until then, the preservatives a formula would need to keep it safe from harmful bacteria would also simultaneously kill off any beneficial live bacteria added to it.
By developing microscopic protective capsules, the researchers were able to keep live probiotic bacteria surviving in a formula for over a year.










